Bicara Therapeutics Inc.(BCAX)
$9.60-0.15 (-1.54%)
BCAX
Bicara Therapeutics Inc. financials statements
$9.60
At close:-0.15 (-1.54%)
Want to see BCAX full AI Analyst Report?
Bicara Therapeutics Inc. (BCAX) Income Statement
93 Followers
Bicara Therapeutics Inc. Income Statement
Last quarter (Q3 2026), Bicara Therapeutics Inc.'s total revenue was $0.00. In Q3, Bicara Therapeutics Inc.'s net income was $-71.25M. See Bicara Therapeutics Inc.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 |
|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 155.60M | $ 82.39M | $ 39.89M | $ 37.66M | |
| Depreciation and Amortization | $ 105.00K | $ 56.00K | $ 19.00K | $ 10.00K |
| $ -137.63M | $ -67.75M | $ -51.96M | $ -37.72M | |
| $ -155.60M | $ -82.39M | $ -39.89M | $ -37.66M | |
| $ 17.87M | $ 14.58M | $ -12.09M | $ -188.00K | |
| $ -137.73M | $ -67.81M | $ -51.98M | $ -37.84M | |
| $ -137.95M | $ -68.00M | $ -51.98M | $ -37.84M | |
| Per Share Metrics | ||||
| Basic EPS | $ -2.52 | $ -1.25 | $ -1.00 | $ -0.73 |
| Diluted EPS | $ -2.52 | $ -1.25 | $ -1.00 | $ -0.73 |
| Weighted Average Shares Outstanding | 54.68M | 54.42M | 51.76M | 51.76M |
| Weighted Average Shares Outstanding (Diluted) | 54.68M | 54.42M | 51.76M | 51.76M |
Currency in USD

